Waters Shareholders Approve Share Issuance for BD Biosciences Combination

Details

The approval was achieved with approximately 99% of votes in favor, and the transaction is expected to close on February 9, 2026, subject to customary closing conditions. This approval marks a significant step towards the completion of the transaction, which will result in SpinCo becoming a wholly owned subsidiary of Waters.

Items reported

About Waters Corporation

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.